Vitae Pharmaceuticals (VTAE) PT Raised to $23 at Wedbush

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/23/2026

1. PATH
2. KBH
3. AZO
4. SPY
5. RCL
6. ONON
7. PLTR
8. PRGS
9. ORCL
10. INNV

Go back to Vitae Pharmaceuticals (VTAE) PT Raised to $23 at Wedbush

Vitae Pharmaceuticals Achieves Proof-of-Concept with First-in-Class RORyt Inhibitor in Moderate to Severe Psoriasis

March 16, 2016 4:05 PM EDT

VTP-43742 demonstrated statistically significant efficacy and was well tolerated             

Company plans to move VTP-43742 forward into 16-week study

Conference call to discuss results at 5:00 p.m. ET, March 16, 2016

James Krueger, M.D., Ph.D.,... More